...
首页> 外文期刊>CNS neuroscience & therapeutics. >Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD)
【24h】

Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD)

机译:NIMH双相情感障碍系统治疗增强计划(STEP-BD)的目的和结果

获取原文
           

摘要

SUMMARY The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD) was funded as part of a National Institute of Mental Health initiative to develop effectiveness information about treatments, illness course, and assessment strategies for severe mental disorders. STEP‐BD studies were planned to be generalizable both to the research knowledge base for bipolar disorder and to clinical care of bipolar patients. Several novel methodologies were developed to aid in illness characterization, and were combined with existing scales on function, quality of life, illness burden, adherence, adverse effects, and temperament to yield a comprehensive data set. The methods integrated naturalistic treatment and randomized clinical trials, which a portion of STEP‐BD participants participated. All investigators and other researchers in this multisite program were trained in a collaborative care model with the objective of retaining a high percentage of enrollees for several years. Articles from STEP‐BD have yielded evidence on risk factors impacting outcomes, suicidality, functional status, recovery, relapse, and caretaker burden. The findings from these studies brought into question the widely practiced use of antidepressants in bipolar depression as well as substantiated the poorly responsive course of bipolar depression despite use of combination strategies. In particular, large studies on the characteristics and course of bipolar depression (the more pervasive pole of the illness), and the outcomes of treatments concluded that adjunctive psychosocial treatments but not adjunctive antidepressants yielded outcomes superior to those achieved with mood stabilizers alone. The majority of patients with bipolar depression concurrently had clinically significant manic symptoms. Anxiety, smoking, and early age of bipolar onset were each associated with increased illness burden. STEP‐BD has established procedures that are relevant to future collaborative research programs aimed at the systematic study of the complex, intrinsically important elements of bipolar disorders.
机译:概述双相情感障碍的系统治疗增强计划(STEP-BD)是国家心理健康研究所倡议的一部分,目的是开发有关严重精神障碍的治疗,疾病过程和评估策略的有效性信息。计划将STEP-BD研究推广到双相情感障碍的研究知识库和双相情感障碍患者的临床护理。已开发了几种新颖的方法来帮助疾病表征,并与功能,生活质量,疾病负担,依从性,不良反应和气质的现有量表相结合,以产生一个综合的数据集。这些方法结合了自然疗法和随机临床试验,STEP-BD参与者的一部分参加了该试验。此多站点计划中的所有研究人员和其他研究人员都接受了协作护理模型的培训,目的是在几年内保留高比例的入学人数。 STEP‐BD上的文章已就影响结果,自杀,功能状态,恢复,复发和看护人负担的风险因素提供了证据。这些研究的发现使人们对在双相抑郁症中广泛使用抗抑郁药提出质疑,并且证实了尽管使用了联合策略,但双相抑郁症的反应性较差。尤其是,有关双相抑郁症(疾病的最普遍极点)的特征和病程的大规模研究以及治疗的结果得出结论,辅助心理社会治疗而非辅助抗抑郁药产生的结果优于单独使用情绪稳定剂获得的结果。大多数双相抑郁症患者同时具有临床上明显的躁狂症状。焦虑,吸烟和双相情感障碍的发病年龄都与疾病负担增加有关。 STEP‐BD已建立了与未来合作研究计划相关的程序,旨在系统研究双相情感障碍的复杂,内在重要的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号